AUTHOR=Feng Youdan , Song Fan , Zhang Peng , Fan Guangda , Zhang Tianyi , Zhao Xiangyu , Ma Chenbin , Sun Yangyang , Song Xiao , Pu Huangsheng , Liu Fei , Zhang Guanglei 

TITLE=Prediction of EGFR Mutation Status in Non–Small Cell Lung Cancer Based on Ensemble Learning

JOURNAL=Frontiers in Pharmacology

VOLUME=13

YEAR=2022

URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.897597

DOI=10.3389/fphar.2022.897597

ISSN=1663-9812

ABSTRACT=<p><bold>Objectives:</bold> We aimed to identify whether ensemble learning can improve the performance of the epidermal growth factor receptor (EGFR) mutation status predicting model.</p><p><bold>Methods:</bold> We retrospectively collected 168 patients with non–small cell lung cancer (NSCLC), who underwent both computed tomography (CT) examination and EGFR test. Using the radiomics features extracted from the CT images, an ensemble model was established with four individual classifiers: logistic regression (LR), support vector machine (SVM), random forest (RF), and extreme gradient boosting (XGBoost). The synthetic minority oversampling technique (SMOTE) was also used to decrease the influence of data imbalance. The performances of the predicting model were evaluated using the area under the curve (AUC).</p><p><bold>Results:</bold> Based on the 26 radiomics features after feature selection, the SVM performed best (AUCs of 0.8634 and 0.7885 on the training and test sets, respectively) among four individual classifiers. The ensemble model of RF, XGBoost, and LR achieved the best performance (AUCs of 0.8465 and 0.8654 on the training and test sets, respectively).</p><p><bold>Conclusion:</bold> Ensemble learning can improve the model performance in predicting the EGFR mutation status of patients with NSCLC, showing potential value in clinical practice.</p>